Brief: TCBP Announces First Patient Completed Full Fose Regimen In ACHIEVE Clinical Trial
12/09/2024 14:16
Sept 12 (Reuters) - TC Biopharm (Holdings) PLC
T0U0y.F :
* TCBP ANNOUNCES FIRST PATIENT COMPLETED THE FULL FOSE
REGIMEN IN
ACHIEVE CLINICAL TRIAL
* TC BIOPHARM LTD: EXPECT TO ANNOUNCE FULL DATA SET IN FIRST
HALF
2025 INCLUSIVE OF PRIMARY, SECONDARY ENDPOINTS
Source text for Eikon: ID:nPncd9jkDa
Further company coverage: T0U0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TC Biopharm (Holdings)
See all newsBrief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: TC BioPharm Announces Complete Response In Minimal Residual Disease Patient
Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Brief: TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML
Brief: TCBP Trading Continues Unabated On Nasdaq Stock Exchange